Clinical Trials Directory

Trials / Unknown

UnknownNCT05835375

A Study to Evaluate the Efficacy of EQ-778 on Upper Respiratory Tract Health Status in Healthy Adults

A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy of EQ-778 on Upper Respiratory Tract Health Status in Healthy Adults

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
374 (estimated)
Sponsor
Vedic Lifesciences Pvt. Ltd. · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is a randomized, double-blind, Placebo Controlled study to evaluate the efficacy of 180 days administration of EQ-778 on upper respiratory tract health status in healthy adults

Conditions

Interventions

TypeNameDescription
OTHEREQ-7781. capsule daily after breakfast (in case of no URTI episode); 2. capsules after breakfast (in case of URTI episode)
OTHERPlacebo1. capsule daily after breakfast (in case of no URTI episode); 2. capsules after breakfast (in case of URTI episode)

Timeline

Start date
2023-08-02
Primary completion
2024-04-26
Completion
2024-04-26
First posted
2023-04-28
Last updated
2024-01-31

Locations

13 sites across 1 country: India

Source: ClinicalTrials.gov record NCT05835375. Inclusion in this directory is not an endorsement.

A Study to Evaluate the Efficacy of EQ-778 on Upper Respiratory Tract Health Status in Healthy Adults (NCT05835375) · Clinical Trials Directory